Abstract: Techniques are described with respect to a system, method, and computer product for visualizing viewpoints. An associated method includes receiving access to a multi-party discussion occurring via a telecommunication system and analyzing the multi-party discussion using natural language processing. The method further includes extracting a plurality of viewpoints of the multi-party discussion based on the analysis, synthesizing a subset of the plurality of viewpoints based on the content of each viewpoint of the plurality of viewpoints, and transmitting a rendered synthesized visualization of the subset.

Abstract: The present application relates to the field of projection technology and discloses a phosphor wheel, a light source module, and a projector. A phosphor wheel includes a base, a first phosphor layer, and a second phosphor layer. The base includes an excitation light reflecting section and an excitation light transmitting section. The first phosphor layer is disposed on a surface of the excitation light reflecting section facing a direction of incident light and spreading along a circumferential direction of the base. The second phosphor layer is disposed on a surface of the excitation light transmitting section facing away from the direction of incident light and spreading along a circumferential direction of the base. The first phosphor layer and the second phosphor layer are offset to each other in a radial direction of the base.

Abstract: The disclosure generally relates to compositions and methods of treating COVID-19 by administering compositions disclosed herein. The methods also include the treatment of post-COVID-19 syndrome and cardiomyopathies using compositions described in the present disclosure.

Abstract: The present invention discloses a train compartment vibration monitoring method and vibration signal feature library establishment and application methods. The non-intrusive train compartment vibration monitoring method only obtains vibration signals of a main measurement point in a train compartment during actual monitoring. The method accurately and truthfully reflects the relationship between the position of a vibration source and the phase offset and amplitude attenuation, can monitor the vibration of an unknown vibration source, and can identify the abnormal vibration to provide a basis for abnormal vibration processing.

Abstract: A training method includes: obtaining a first recommendation model, where a model parameter of the first recommendation model is obtained through training based on n first training samples; determining an impact function value of each first training sample with respect to a verification loss of m second training samples in the first recommendation model; determining, based on the impact function value of each first training sample with respect to the verification loss, a weight corresponding to each first training sample; and training the first recommendation model based on the n first training samples and the weights corresponding to the n first training samples, to obtain a target recommendation model.

Abstract: The present invention discloses a method and system for training a passenger distribution prediction model, and a method and system for guiding passengers. In an embodiment, the passenger distribution is intelligently sensed by means of the characteristics of temperature, humidity and CO2 concentration distribution changes in cars caused by passenger density changes, which avoids the problems of crowd flow and obscuration faced by passenger distribution detection conducted with images, and avoids the difficulty in floor intrusive transformation faced by passenger distribution detection conducted with pressure sensors; the passenger flow is guided by adjusting the brightness of lighting tubes in the cars, for example, the lighting tubes in areas with high passenger density are dimmed, and the lighting tubes in areas with low passenger density are brightened, to guide ordered flow of passengers toward areas with low passenger density. Further details are disclosed herein.

Abstract: A method of manufacturing a high-strength synthetic fiber utilizing high-temperature multi-sectional drawing, two-stage high-temperature multi-sectional drawing, or multi-stage high-temperature multi-sectional drawing. The method comprises the following steps: performing, on a synthetic resin, melt spinning or melt extrusion, cooling, multi-sectional high-temperature drawing, heat setting and a fiber surface treatment, wherein the multi-sectional high-temperature drawing comprises independently adjusting temperatures at a front section and a rear section of an furnace, and the temperature at the rear section is higher than that at the front section. The temperature adjustment is performed on different locations in the furnace and according to a crystallization orientation of a fiber molecular chain, significantly increasing fiber strength. The method is widely applicable to manufacturing of various types of fibers, enhancing application performance of the fibers.

Abstract: The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1? binding antibody or functional fragment thereof.

Abstract: The present disclosure relates to PDE9 inhibitors, pharmaceutical compositions comprising the PDE9 inhibitors, and methods of using the PDE9 pharmaceutical compositions for the treatment of sickle cell disease (SCD).

Abstract: The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1? binding antibody or functional fragment thereof.

Abstract: A method of manufacturing a high-strength synthetic fiber utilizing high-temperature multi-sectional drawing, two-stage high-temperature multi-sectional drawing, or multi-stage high-temperature multi-sectional drawing. The method comprises the following steps: performing, on a synthetic resin, melt spinning or melt extrusion, cooling, multi-sectional high-temperature drawing, heat setting and a fiber surface treatment, wherein the multi-sectional high-temperature drawing comprises independently adjusting temperatures at a front section and a rear section of an furnace, and the temperature at the rear section is higher than that at the front section. The temperature adjustment is performed on different locations in the furnace and according to a crystallization orientation of a fiber molecular chain, significantly increasing fiber strength. The method is widely applicable to manufacturing of various types of fibers, enhancing application performance of the fibers.

Abstract: The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1? binding antibody or functional fragment thereof.

Abstract: Memory systems may include a memory including a plurality of wordlines, each wordline including a plurality of cells, and a controller suitable for obtaining an initial voltage threshold and a target state for each of the plurality of cells, applying a pulse based on a pulse value to the plurality of cells, and calculating at least one coupling effect to neighboring cells.

Abstract: The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1? binding antibody or functional fragment thereof.

Abstract: Memory systems may include a memory including a plurality of wordlines, each wordline including a plurality of cells, and a controller suitable for obtaining an initial voltage threshold and a target state for each of the plurality of cells, applying a pulse based on a pulse value to the plurality of cells, and calculating at least one coupling effect to neighboring cells.

Abstract: The present invention relates to a method for treating or alleviating the symptoms of peripheral arterial disease (PAD) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1? binding antibody or functional fragment thereof.

Abstract: A non-contact measuring method in pediatrics is disclosed. An infant model is established by acquiring a human image and a depth image of a subject infant; updating the infant model by acquiring a plurality of anthropometric characteristic points and finally obtaining an anthropometric data of the subject infant from the updated infant model. This invention also provides an apparatus to achieve the above mentioned measuring method. An infant model which includes anthropometric characteristic points and 3D surface models is established based on a human image acquired by an image acquisition module and a depth image acquired by a depth information acquisition module in conjunction with an algorithm program built in a data acquisition and processing module. Human anthropometric data is obtained by analyzing the infant model. The non-contact measuring method and measuring apparatus in pediatrics make the measuring process more humane without contacting a subject body.

Abstract: The present invention provides the use of a neutral endopeptidase inhibitor, in the manufacture of a medicament for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The invention also relates to the use of a compound of Formula I: wherein R1, R2, R3, R5, X, A3, B1, s and n are defined herein, for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of contrast-induced nephropathy.

Abstract: The present invention provides the use of a neutral endopeptidase inhibitor, in the manufacture of a medicament for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The invention also relates to the use of a compound of Formula I: wherein R1, R2, R3, R5, X, A3, B1, s and n are defined herein, for the treatment, amelioration and/or prevention of contrast-induced nephropathy. The present invention further provides a combination of pharmacologically active agents for use in the treatment, amelioration and/or prevention of contrast-induced nephropathy.

Abstract: A non-contact measuring method in pediatrics is disclosed. An infant model is established by acquiring a human image and a depth image of a subject infant; updating the infant model by acquiring a plurality of anthropometric characteristic points and finally obtaining an anthropometric data of the subject infant from the updated infant model. This invention also provides an apparatus to achieve the above mentioned measuring method. An infant model which includes anthropometric characteristic points and 3D surface models is established based on a human image acquired by an image acquisition module and a depth image acquired by a depth information acquisition module in conjunction with an algorithm program built in a data acquisition and processing module. Human anthropometric data is obtained by analyzing the infant model. The non-contact measuring method and measuring apparatus in pediatrics make the measuring process more humane without contacting a subject body.